BioVentrix Launches Novel Revivent Myocardial Anchoring System at Renowned European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
October 25, 2012 08:35 ET
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) - Techno-College Booth 005; EACTS Booth 92/93 - BioVentrix, the developer of minimally invasive heart failure therapies, today introduced the...
BioVentrix lance son nouveau système d'ancrage myocardique Revivent à l'occasion de la réunion annuelle réputée de l'Association Européenne pour la Chirurgie Cardio-Thoracique (EACTS)
October 25, 2012 03:35 ET
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Stand Techno-College 005 ; Stand EACTS 92/93 - BioVentrix, le développeur de traitements mini-invasifs contre les insuffisances...
BioVentrix lanceert nieuw Revivent Myocardial Anchoring Systeem op de jaarlijkse bijeenkomst van de vermaarde Europese Associatie voor Thoraxchirurgie (EACTS)
October 25, 2012 03:35 ET
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Techno-College Stand 005; EACTS Stand 92/93 - BioVentrix, de ontwikkelaar van minimaal invasieve hartfalen therapieën, introduceerde vandaag...
BioVentrix lanciail nuovo sistema di ancoraggio del miocardio Reviventin occasione del congresso annuale della prestigiosaEuropean Association for Cardio-Thoracic Surgery (EACTS)
October 25, 2012 03:35 ET
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Stand Techno-College005; stand EACTS 92/93 - BioVentrix, azienda operante nel settore dello sviluppo di terapie per l'insufficienza cardiaca...
BioVentrix führt im Rahmen der Jahresversammlung der European Association for Cardio-Thoracic Surgery (EACTS) ein neues Revivent-System zur Verankerung im Herzmuskel ein
October 25, 2012 03:35 ET
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Techno-College-Stand 005; EACTS-Stand 92/93 – BioVentrix, der Entwickler von minimalinvasiven Herzinsuffizienztherapien, stellte heute das...
BioVentrix lanza novedoso sistema de anclaje del miocardio Revivent en la reunión anual de la célebre Asociación Europea de Cirugía Cardiotorácica (EACTS)
October 25, 2012 03:35 ET
|
BioVentrix
BARCELONA, ESPAÑA--(Marketwire - Oct 25, 2012) -
Stand 005 Techno-College; Stand 92/93 de EACTS - BioVentrix, el desarrollador de terapias mínimamente invasivas para el tratamiento de...
BioVentrix Reports Favorable Patient Outcomes for Heart Failure Treatment at TCT 2012
October 23, 2012 08:35 ET
|
BioVentrix
SAN RAMON, CA--(Marketwire - Oct 23, 2012) - Results from a clinical abstract to be presented at the TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the...
BioVentrix Initiates Phase II Study of Revivent System for Less Invasive Heart Failure Treatment in Western Europe
October 03, 2012 08:29 ET
|
BioVentrix
SAN RAMON, CA--(Marketwire - Oct 3, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, today announced the initiation of a Phase II clinical trial...
BioVentrix Announces Newly Elected Members to Board of Directors
June 18, 2012 08:35 ET
|
BioVentrix
SAN RAMON, CA--(Marketwire - Jun 18, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, announced the election of Mr. George J. Fazio and Mr....
BioVentrix Selected to Present at Prestigious EuroPCR Meeting
May 14, 2012 08:00 ET
|
BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, was selected to present at EuroPCR, the annual meeting of the...